Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells

Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, Texas, United States
Journal of Biological Chemistry (Impact Factor: 4.6). 03/2006; 281(7):4334-8. DOI: 10.1074/jbc.M512830200
Source: PubMed

ABSTRACT ISG15 is an interferon (IFN)-alpha/beta-induced ubiquitin-like protein that is conjugated to cellular proteins during innate immune responses to viral and bacterial infections. A recent proteomics study identified 158 human proteins targeted for ISG15 conjugation, including the ISG15 E1 and E2 enzymes (Ube1L and UbcH8, respectively) and a HECT E3 enzyme, Herc5. Like the genes encoding Ube1L and UbcH8, expression of Herc5 was also induced by IFN-beta, suggesting that Herc5 might be a component of the ISG15 conjugation system. Consistent with this, small interfering RNAs targeting Herc5 had a dramatic effect on overall ISG15 conjugation in human cells, abrogating conjugation to the vast majority of ISG15 target proteins in vivo. In addition, co-transfection of plasmids expressing ISG15, Ube1L, UbcH8, and Herc5 resulted in robust ISG15 conjugation in non-IFN-treated cells, while the active-site cysteine mutant of Herc5 or a mutant lacking the RCC1 repeat region did not support ISG15 conjugation. These results demonstrate that Herc5 is required for conjugation of ISG15 to a broad spectrum of target proteins in human cells.

  • Source
    • "For example, ISG15 (first reported in 1978) contains two ubiquitin-like domains linked by a hinge, and the C-terminal LRLRGG motif is responsible for its conjugating onto target proteins. ISG15 and its E1 activating enzyme Ube1L, E2 conjugating enzyme UbcH8, E3 ligase Herc5 are all robustly induced upon viral infection or lipopolysaccharide (LPS) treatment, causing the ISGylation of a wide spectrum of proteins [18] [19] [20] [21] [22]. The functional consequences of ISGylation are currently under intensive investigation . "
    [Show abstract] [Hide abstract]
    ABSTRACT: Protein post-translational modifications (PTMs) are central to the host innate immune regulations. Dynamically, PTMs fine-tune the spatial and temporary responses of immune- and non-immune-cells, in accordance with extracellular and intracellular stresses. Ubiquitin and ubiquitin-like proteins (Ubls) are emerging as the important multi-functional signals, controlling the activation, stability, affinity and location of many signaling proteins. Recent investigations, at the molecular-cellular-animal models, have shed new light on the versatility of the ubiquitin, SUMO and ISG15, for shaping the strength and duration of the innate immune responses. This review summarizes our current knowledge on the functions and regulatory mechanisms of the ubiquitin and Ubls in the innate immunity, the first line of host defense against microbial infection.
    Cytokine & growth factor reviews 08/2013; 24(6). DOI:10.1016/j.cytogfr.2013.07.002 · 6.54 Impact Factor
  • Source
    • "There was no significant difference in the viability of cells expressing HERC5 + CS compared to the control cells (92.0% ± 4.3% SD versus 90.2% ± 4.4% SD respectively; P > 0.05, paired t test). Western blot analysis of the cell lysates revealed the presence of ISG15 conjugates in cells transfected with the CS and HERC5, but not the cells transfected with the CS and empty vector or HERC5-C994A, thus supporting previous data (Figure 4B, upper blot)(Dastur et al., 2006; Wong et al., 2006). We also verify that HERC5, but not HERC5-C994A, can conjugate ISG15 to itself (Figure 4B, lower blot). "
    [Show abstract] [Hide abstract]
    ABSTRACT: 1 Abstract Type I interferon (IFN-I)-treated cells fail to support viral replication in vitro. The identification and characterization of key IFN-I-induced proteins has provided insight into the antiviral effector mechanisms of the Type I interferon response. Using HIV-1 as a model system, several of these host-derived factors have been shown to inhibit unique stages in the HIV-1 life cycle. Here we highlight and expand our previous findings identifying HECT domain and RCC1-like domain-containing protein 5 (HERC5) as a novel host-derived inhibitor of a late stage of HIV-1 particle production.
    Advances in Virus Research, 01/2013; iConcept Press., ISBN: 978-14775550-4-0
  • Source
    • "DNA encoding the isolated HECT domain of mHERC6 (aminoacids (aa) 658–1003) and the RCC1-like domain truncation mutant (aminoacids (aa) 371–1003) were amplified via PCR and cloned into the pTriEx-2 vector. Plasmids encoding human Ube1l and human UbcH8 were described previously [21]. Murine and human ISG15 were expressed using pcDNA3.1 (Invitrogen). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Posttranslational protein modification by ubiquitin and ubiquitin-like modifiers (UBLs) is mediated by a hierarchical cascade of conjugating enzymes and affects multiple biological processes within the cell. Interferon-stimulated gene 15 (ISG15) is an UBL, which is strongly induced by type I Interferon and ISG15 modification was shown to play an essential role in antiviral defense. While hHERC5 is the major E3 ligase for ISG15 modification in humans, ISGylation in the murine systems at the level of E3 ligases was weakly characterized as rodent genomes lack a direct homologue of hHERC5. Here, we show that mHERC6 is strongly induced by different pathogen-associated molecular patterns (PAMPs) in a type I Interferon receptor (IFNAR1) dependent manner. We demonstrate that mHERC6 is essential for endogenous murine ISGylation and thus represents the dominant ISG15 E3 ligase in mice. In contrast to its human homologue, mHERC6 is also capable to mediate conjugation of human ISG15.
    Biochemical and Biophysical Research Communications 11/2011; 417(1):135-40. DOI:10.1016/j.bbrc.2011.11.071 · 2.28 Impact Factor
Show more